BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kasper S, Dold M. Factors contributing to the increasing placebo response in antidepressant trials. World Psychiatry 2015;14:304-6. [PMID: 26407782 DOI: 10.1002/wps.20245] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Breilmann J, Furukawa TA, Becker T, Koesters M. Differences in the placebo response in duloxetine and venlafaxine trials. Acta Psychiatr Scand 2018;137:472-80. [DOI: 10.1111/acps.12881] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
2 Javed A. WPA Scientific Sections: update on the activities. World Psychiatry 2016;15:191-2. [PMID: 27265720 DOI: 10.1002/wps.20317] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
3 Razza LB, Moffa AH, Moreno ML, Carvalho AF, Padberg F, Fregni F, Brunoni AR. A systematic review and meta-analysis on placebo response to repetitive transcranial magnetic stimulation for depression trials. Prog Neuropsychopharmacol Biol Psychiatry 2018;81:105-13. [PMID: 29111404 DOI: 10.1016/j.pnpbp.2017.10.016] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 8.0] [Reference Citation Analysis]
4 Dold M, Bartova L, Kasper S. Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic Treatment. Int J Neuropsychopharmacol 2020;23:440-5. [PMID: 32570275 DOI: 10.1093/ijnp/pyaa034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
5 Khan A, Fahl Mar K, Faucett J, Khan Schilling S, Brown WA. Has the rising placebo response impacted antidepressant clinical trial outcome? Data from the US Food and Drug Administration 1987-2013. World Psychiatry 2017;16:181-92. [PMID: 28498591 DOI: 10.1002/wps.20421] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 9.2] [Reference Citation Analysis]
6 Kotzalidis GD, Del Casale A, Simmaco M, Pancheri L, Brugnoli R, Paolini M, Gualtieri I, Ferracuti S, Savoja V, Cuomo I, De Chiara L, Mosca A, Sani G, Girardi P, Pompili M, Rapinesi C, On Behalf Of The Sapienza Group For The Study Of The Placebo Effect In Psychiatric Disorders. Placebo Effect in Obsessive-Compulsive Disorder (OCD). Placebo Response and Placebo Responders in OCD: The Trend Over Time. Curr Neuropharmacol 2019;17:741-74. [PMID: 30370851 DOI: 10.2174/1570159X16666181026163922] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]